These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8799521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.
    Aros CA, Ardiles LG, Schneider HO, Flores CA, Alruiz PA, Jerez VR, Mezzano SA.
    Transplant Proc; 2005 Oct; 37(8):3364-6. PubMed ID: 16298597
    [Abstract] [Full Text] [Related]

  • 3. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H, Wagner C, Korn A, Christians U.
    Med Klin (Munich); 1997 Oct 15; 92(10):589-96. PubMed ID: 9446006
    [Abstract] [Full Text] [Related]

  • 4. Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?
    Christians U, Bleck JS, Lampen A, Bader A, Thiesemann C, Kliem V, Repp H, Westhoff-Bleck M, Manns M, Sewing KF.
    Transplant Proc; 1996 Aug 15; 28(4):2159-61. PubMed ID: 8769186
    [No Abstract] [Full Text] [Related]

  • 5. Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.
    Foradori A, Mezzano S, Videla C, Pefaur J, Elberg A.
    Transplant Proc; 1998 Aug 15; 30(5):1685-7. PubMed ID: 9723244
    [No Abstract] [Full Text] [Related]

  • 6. Diltiazem-cyclosporin pharmacokinetic interaction--dose-response relationship.
    Jones TE, Morris RG, Mathew TH.
    Br J Clin Pharmacol; 1997 Nov 15; 44(5):499-504. PubMed ID: 9384468
    [Abstract] [Full Text] [Related]

  • 7. Alternative cyclosporine metabolic pathways and toxicity.
    Christians U, Sewing KF.
    Clin Biochem; 1995 Dec 15; 28(6):547-59. PubMed ID: 8595701
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.
    Jones TE, Morris RG.
    Clin Pharmacokinet; 2002 Dec 15; 41(5):381-8. PubMed ID: 12036394
    [Abstract] [Full Text] [Related]

  • 9. Diltiazem does not always increase blood cyclosporin concentration.
    Jones TE, Morris RG.
    Br J Clin Pharmacol; 1996 Nov 15; 42(5):642-4. PubMed ID: 8951199
    [Abstract] [Full Text] [Related]

  • 10. The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus.
    Akhlaghi F, Dostalek M, Falck P, Mendonza AE, Amundsen R, Gohh RY, Asberg A.
    Ther Drug Monit; 2012 Feb 15; 34(1):38-45. PubMed ID: 22210099
    [Abstract] [Full Text] [Related]

  • 11. Correlation Between C2 and AUC(0-4) in Renal Transplant Patients Treated With Diltiazem.
    Aros CA, Schneider HO, Flores CA, Ardiles LG, Alruiz PA, Jerez V, Mezzano SA.
    Transplant Proc; 2005 Apr 15; 37(3):1580-2. PubMed ID: 15866679
    [Abstract] [Full Text] [Related]

  • 12. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S, Gumustekin M, Aygoren O, Tuncok Y, Gelal A, Guven H.
    Eur J Drug Metab Pharmacokinet; 2004 Apr 15; 29(2):119-23. PubMed ID: 15230340
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW, Siekmeier R, Lattke P, Merz M, Mix C, Schüler S, Jaross W.
    J Cardiovasc Pharmacol Ther; 2001 Oct 15; 6(4):351-61. PubMed ID: 11907637
    [Abstract] [Full Text] [Related]

  • 14. Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients.
    Smith CL, Hampton EM, Pederson JA, Pennington LR, Bourne DW.
    Pharmacotherapy; 1994 Oct 15; 14(4):471-81. PubMed ID: 7937285
    [Abstract] [Full Text] [Related]

  • 15. Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
    McLachlan AJ, Tett SE.
    Ther Drug Monit; 1998 Aug 15; 20(4):390-5. PubMed ID: 9712463
    [Abstract] [Full Text] [Related]

  • 16. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients.
    Roy LF, East DS, Browning FM, Shaw D, Ogilvie RI, Cardella C, Leenen FH.
    Clin Pharmacol Ther; 1989 Dec 15; 46(6):657-67. PubMed ID: 2689045
    [Abstract] [Full Text] [Related]

  • 17. Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil.
    Jacob LP, Malhotra D, Chan L, Shapiro JI.
    Am J Kidney Dis; 1999 Feb 15; 33(2):301-3. PubMed ID: 10023642
    [Abstract] [Full Text] [Related]

  • 18. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
    Hermann M, Asberg A, Christensen H, Reubsaet JL, Holdaas H, Hartmann A.
    Eur J Clin Pharmacol; 2005 Mar 15; 61(1):59-62. PubMed ID: 15711834
    [Abstract] [Full Text] [Related]

  • 19. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K, Kirchner GI, Rupprecht L, Gruber M, Birnbaum DE, Schmid FX, Preuner JG.
    Transplant Proc; 2007 Dec 15; 39(10):3323-8. PubMed ID: 18089380
    [Abstract] [Full Text] [Related]

  • 20. Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in rats.
    Koehler J, Kuehnel T, Kees F, Hoecherl K, Grobecker HF.
    Drug Metab Dispos; 2002 Jun 15; 30(6):658-62. PubMed ID: 12019192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.